Afanat 30 (Afatinib) Tablets
Afanat 30 Tablet is an anti-cancer medicine used in the treatment of non-small cell lung cancer (NSCLC). It is a common form of lung cancer in which abnormal cells grow in the lung tissues.
| Brand Name | Afanat |
| Generic Name | Afatinib |
| Strength | 30 mg |
| Manufacturer | Natco Pharma Ltd. |
Product Overview
Afanat 30 Tablet contains Afatinib, which belongs to the class of medicines known as kinase inhibitors. It works by stopping the action of a tyrosine kinase enzyme that causes the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body. It also decreases the blood supply to cancer tumors to slow down the growth of the tumor.
Answers to What Matters
Strengthening healthcare delivery through long-standing collaborations built on quality, reliability, and shared purpose.
We supply a comprehensive range of essential, specialty, super specialty, and critical care pharmaceutical products across multiple therapeutic segments.
Yes, we cater to all pin codes in India and ensure delivery through reliable courier services.
We work with hospitals, pharmacies, clinics, healthcare institutions, distributors, and patients through approved supply channels.
Yes. We provide prompt support for urgent and critical medicine needs, subject to availability and compliance requirements.
All products are sourced from authorised manufacturers and handled under strict GDP-compliant storage, documentation, and distribution protocols.
We accept multiple payment modes, including bank transfer, UPI, and other approved digital payment options, as per applicable terms.
Our team typically responds within one business working day.
Yes. Home delivery is available where permitted, ensuring safe and compliant last-stage delivery of medicines.
You can reach us through the enquiry form on our website or contact our team directly for assistance.
Let’s Build a Reliable Pharma Partnership
Reach out to explore how we can support your pharma requirements.
